NEW YORK (GenomeWeb News) – Hologic reported after the close of the market Monday that its fourth-quarter 2012 revenues climbed 26 percent year over year with a large chunk of that increase due to Gen-Probe's sales contribution.

The Bedford, Mass.-based diagnostics, medical imaging, and surgical products firm reported total revenues of $588.5 million for the three months ended Sept. 29, up from $467.0 million for the fourth quarter of 2011. It beat the consensus Wall Street estimate of $581.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.